REDDING, Calif., Oct. 24, 2024 /PRNewswire/ -- According to a new market research report, 'IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, ...
ST. CLOUD, Minn., Sept. 10, 2020 /PRNewswire/ -- Offering a comprehensive portfolio of SARS-CoV-2 molecular QC standards, Microbiologics is launching IVD Process Controls and Inactivated Whole Virus ...
IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...
The new partnership combines QIAGEN’s QIAcuityDx digital PCR platform to advance sensitive, cost-effective oncology diagnostics with GENCURIX’s expertise in multiplex assay development. The aim is to ...
ST. CLOUD, Minn.--(BUSINESS WIRE)--Offering a comprehensive portfolio of SARS-CoV-2 molecular QC standards, Microbiologics is launching IVD Process Controls and Inactivated Whole Virus Controls to ...
GENCURIX signs as inaugural partner to develop multiplex oncology assays for tissue and liquid biopsies Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback